United Kingdom Renal Denervation Market Report 2022-2027: Rising Numbers Suffering with Hypertension Augmenting Sector Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “United Kingdom Renal Denervation Market, By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Micro-infusion), By Product, By Therapeutic Area, By End User, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering.

United Kingdom renal denervation market may flourish with an impressive CAGR during the forecast period of 2023-2027, on the backbone of increasing number of patients suffering from hypertension. Rising instances of high blood pressure among the population drives the growth of the United Kingdom renal denervation market in the upcoming five years.

Growing instances of therapy resistant hypertension may also be considered as a key growth factor for the United Kingdom renal denervation market in the next five years. The population in the United kingdom is highly inclined towards consumption of junk food and fast food. Online delivery of the food & groceries adds to the convenience of the working class population living a highly sedentary lifestyle. Growing instances of younger population being involved with heavy alcohol consumption and smoking also fuels the growing risks of high blood pressure thereby aiding the growth of the United Kingdom renal denervation market in the future five years.

Report Scope:

In this report, United Kingdom renal denervation market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

United Kingdom Renal Denervation Market, By Technology:

  • Ultrasound Ablation
  • Radiofrequency Ablation
  • Pharmacologic Ablation
  • Micro-infusion

United Kingdom Renal Denervation Market, By Product:

  • Catheters
  • Single Electrode Catheter
  • Multi Electrode Catheter
  • RF Generator
  • Others

United Kingdom Renal Denervation Market, By Therapeutic Area:

  • Hypertension
  • Heart Failure
  • Diabetes
  • Renal Failure
  • Others

United Kingdom Renal Denervation Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

United Kingdom Renal Denervation Market, By Region:

  • London
  • East Anglia
  • Southwest
  • Southeast
  • Scotland
  • East Midlands
  • Yorkshire & Humberside

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on United Kingdom Renal Denervation Market

5. Voice of Customer

6. United Kingdom Renal Denervation Market Outlook

7. London Renal Denervation Market Outlook

8. East Anglia Renal Denervation Market Outlook

9. Southwest Renal Denervation Market Outlook

10. Southeast Renal Denervation Market Outlook

11. Scotland Renal Denervation Market Outlook

12. East Midlands Renal Denervation Market Outlook

13. Yorkshire & Humberside Renal Denervation Market Outlook

14. Market Dynamics

15. Market Trends & Developments

16. Policy & Regulatory Landscape

17. United Kingdom Economic Profile

18. Competitive Landscape

19. Strategic Recommendations

Companies Mentioned

  • Medtronic United Kingdom
  • Boston Scientific Limited
  • Abbott Laboratories Limited
  • CardioSonic Limited
  • Terumo UK Limited
  • Johnson & Johnson Limited

For more information about this report visit https://www.researchandmarkets.com/r/eeve04

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900